Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial.

Toshko Lissitchkov; Bella Madan; Claudia Djambas Khayat; Nadezhda Zozulya; Cecil Ross; Mehran Karimi; Kaan Kavakli; Guillermo R De Angulo; Abdulkareem Almomen; Bruce A Schwartz; Cristina Solomon; Sigurd Knaub; Flora Peyvandi

doi:10.1111/trf.14421

Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial.

Toshko Lissitchkov
, Bella Madan
, Claudia Djambas Khayat
, Nadezhda Zozulya
, Cecil Ross
, Mehran Karimi
, Kaan Kavakli
, Guillermo R De Angulo
, Abdulkareem Almomen
, Bruce A Schwartz
, Cristina Solomon
, Sigurd Knaub
, Flora Peyvandi

Department of Anaesthesiology

Research output: Contribution to journal › Original Article › peer-review

19 Citations (Web of Science)

Original language	English
Pages (from-to)	413-422
Journal	TRANSFUSION
Volume	58
Issue number	2
DOIs	https://doi.org/10.1111/trf.14421
Publication status	Published - 2018

Keywords

VON-WILLEBRAND-DISEASE
CENTER-DOCTORS-ORGANIZATION
INHERITED AFIBRINOGENEMIA
COAGULATION DISORDERS
REPLACEMENT THERAPY
BLEEDING DISORDERS
CRYOPRECIPITATE
PHARMACOKINETICS
HEMOPHILIA
GUIDELINES

Access to Document

10.1111/trf.14421

Cite this

Lissitchkov, T., Madan, B., Djambas Khayat, C., Zozulya, N., Ross, C., Karimi, M., Kavakli, K., De Angulo, G. R., Almomen, A., Schwartz, B. A., Solomon, C., Knaub, S., & Peyvandi, F. (2018). Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial. TRANSFUSION , 58(2), 413-422. https://doi.org/10.1111/trf.14421

Lissitchkov, Toshko ; Madan, Bella ; Djambas Khayat, Claudia et al. / Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial. In: TRANSFUSION 2018 ; Vol. 58, No. 2. pp. 413-422.

@article{d3120cf1d1234acfa4008a86e4429ada,

title = "Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial.",

keywords = "VON-WILLEBRAND-DISEASE, CENTER-DOCTORS-ORGANIZATION, INHERITED AFIBRINOGENEMIA, COAGULATION DISORDERS, REPLACEMENT THERAPY, BLEEDING DISORDERS, CRYOPRECIPITATE, PHARMACOKINETICS, HEMOPHILIA, GUIDELINES",

author = "Toshko Lissitchkov and Bella Madan and \{Djambas Khayat\}, Claudia and Nadezhda Zozulya and Cecil Ross and Mehran Karimi and Kaan Kavakli and \{De Angulo\}, \{Guillermo R\} and Abdulkareem Almomen and Schwartz, \{Bruce A\} and Cristina Solomon and Sigurd Knaub and Flora Peyvandi",

note = "Solomon,: Paracelsus Med Univ, Salzburg Univ Hosp, Dept Anesthesiol Perioperat Care \& Gen Intens Car, Salzburg, Austria;",

year = "2018",

doi = "10.1111/trf.14421",

language = "English",

volume = "58",

pages = "413--422",

journal = "TRANSFUSION ",

issn = "0041-1132",

publisher = "Wiley Verlag ",

number = "2",

}

Lissitchkov, T, Madan, B, Djambas Khayat, C, Zozulya, N, Ross, C, Karimi, M, Kavakli, K, De Angulo, GR, Almomen, A, Schwartz, BA, Solomon, C, Knaub, S & Peyvandi, F 2018, 'Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial.', TRANSFUSION , vol. 58, no. 2, pp. 413-422. https://doi.org/10.1111/trf.14421

Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial. / Lissitchkov, Toshko; Madan, Bella; Djambas Khayat, Claudia et al.
In: TRANSFUSION , Vol. 58, No. 2, 2018, p. 413-422.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial.

AU - Lissitchkov, Toshko

AU - Madan, Bella

AU - Djambas Khayat, Claudia

AU - Zozulya, Nadezhda

AU - Ross, Cecil

AU - Karimi, Mehran

AU - Kavakli, Kaan

AU - De Angulo, Guillermo R

AU - Almomen, Abdulkareem

AU - Schwartz, Bruce A

AU - Solomon, Cristina

AU - Knaub, Sigurd

AU - Peyvandi, Flora

N1 - Solomon,: Paracelsus Med Univ, Salzburg Univ Hosp, Dept Anesthesiol Perioperat Care & Gen Intens Car, Salzburg, Austria;

PY - 2018

Y1 - 2018

KW - VON-WILLEBRAND-DISEASE

KW - CENTER-DOCTORS-ORGANIZATION

KW - INHERITED AFIBRINOGENEMIA

KW - COAGULATION DISORDERS

KW - REPLACEMENT THERAPY

KW - BLEEDING DISORDERS

KW - CRYOPRECIPITATE

KW - PHARMACOKINETICS

KW - HEMOPHILIA

KW - GUIDELINES

U2 - 10.1111/trf.14421

DO - 10.1111/trf.14421

M3 - Original Article

C2 - 29194665

SN - 0041-1132

VL - 58

SP - 413

EP - 422

JO - TRANSFUSION

JF - TRANSFUSION

IS - 2

ER -

Lissitchkov T, Madan B, Djambas Khayat C, Zozulya N, Ross C, Karimi M et al. Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial. TRANSFUSION . 2018;58(2):413-422. doi: 10.1111/trf.14421